Home > 
News
Print

07 April 2005 - Proteo Biotech AG to go to clinical trials with Elafin and selects Eurogentec for cGMP manufacturing


Proteo Biotech selects Eurogentec for the manufacturing of their anti-inflammatory protein Elafin because its expertise. Visit the Proteo biotech website for more details. http://proteo.de/pages/presse.php?DATUM=2005-04-07&BACK=/pages/presse_01_02.php&lang=en
Back to news list

To receive relevant information on our products, you should first select your country :
Country selection page

Feedback Form